AtkinsRéalis Group (ATRL) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Aug, 2026Executive summary
Achieved Q2 revenue of $3.0 billion (CAD 3 billion), up 10% year-over-year, with adjusted EBITDA rising 14% to $293 million and adjusted EPS up 20% to $0.97; organic revenue growth was 8.3%.
Backlog reached $20.2 billion, with engineering services backlog at a record $13.4 billion; nuclear segment revenue grew 18% and outlook for 2026 was raised to $2.7 billion.
Strategic acquisitions in Australia and Ireland, and AI integration, expanded presence in high-growth markets and enhanced technology leadership.
Returned $245 million to shareholders via share repurchases and dividends in Q2 2026.
Board strengthened with technology and AI expertise.
Financial highlights
Q2 total revenue: $3.0 billion, up 10% year-over-year; organic revenue growth was 8.3%.
Adjusted EBITDA: $293 million, up 14% year-over-year; margin at 9.8%.
Adjusted EPS: $0.97, up 20% from $0.81 in Q2 2025.
Net cash from operating activities: $84 million, significantly improved year-over-year.
Corporate SG&A expenses: $28 million, a 24% improvement year-over-year.
Outlook and guidance
Raised 2026 nuclear revenue outlook to approximately $2.7 billion (from $2.5 billion).
Engineering services regions organic growth expected toward the lower end of the 5% range due to Middle East conflict.
2027 nuclear revenue guidance remains $2.6–3 billion, aiming for the top half of the range.
Net cash from operating activities forecasted at ~$500 million for 2026.
Effective tax rate expected between 25–30%.
Latest events from AtkinsRéalis Group
- Revenue up 18% and net income up 34%, driven by strong Nuclear and Engineering Services growth.ATRL
Q1 2026 - Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 2025 - Q3 2025 delivered record revenue, backlog, and margin growth, led by strong Nuclear and Engineering Services gains.ATRL
Q3 2025 - Record revenue, backlog, and nuclear growth highlight a transformative Q2 with major asset sale.ATRL
Q2 2025 - Q3 2024 delivered record Nuclear backlog, margin gains, and robust cash flow generation.ATRL
Q3 2024 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight robust Q2 results.ATRL
Q2 2024 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 2024 - Record backlog and surging Nuclear growth drive raised outlook and strong Q1 2025 results.ATRL
Q1 2025 - Record 2024 results, $2.8B asset sale, and strong 2025 growth outlook.ATRL
Q4 2024